Search Results for "drug"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for drug. Results 81 to 90 of 2680 total matches.

Drug Interactions with Grapefruit Juice

   
The Medical Letter on Drugs and Therapeutics • Jan 05, 2004  (Issue 1173)
Drug Interactions with Grapefruit Juice ...
The ability of grapefruit juice to increase serum concentrations of drugs was first discovered during a study of the effect of ethanol on felodipine (Plendil) pharmacokinetics. Double-strength grapefruit juice used to disguise the taste of ethanol resulted in higher than expected serum concentrations of felodipine (DG Bailey et al, Clin Invest Med 1989; 12:357).
Med Lett Drugs Ther. 2004 Jan 5;46(1173):2-4 |  Show IntroductionHide Introduction

Drugs for Opioid Use Disorder

   
The Medical Letter on Drugs and Therapeutics • Sep 04, 2023  (Issue 1684)
Drugs for Opioid Use Disorder ...
Opioid use disorder is a chronic, relapsing disease with physical and psychiatric components. It is associated with economic hardship, social isolation, incarceration, increased rates of blood-borne infections such as HIV and viral hepatitis, adverse pregnancy outcomes, and increased mortality. According to the NIH, there were 80,411 deaths involving an opioid in the US in 2021, more than in any previous year. Several guidelines on the management of opioid use disorder are available; all recommend maintenance pharmacotherapy as the standard of care.
Med Lett Drugs Ther. 2023 Sep 4;65(1684):137-44   doi:10.58347/tml.2023.1684a |  Show IntroductionHide Introduction

Drugs and Devices for Weight Management

   
The Medical Letter on Drugs and Therapeutics • Aug 04, 2025  (Issue 1734)
Drugs and Devices for Weight Management ...
Overweight is generally defined as a body mass index (BMI) between 25 and 29.9 kg/m2 in adults. A BMI ≥30 is considered obese (criteria differ slightly in Asian patients). In patients with an elevated BMI, a 5-10% reduction in weight has been associated with a reduction in the risk of developing type 2 diabetes, hypertension, and dyslipidemia. Diet, exercise, and behavior modification are the traditional methods for losing weight, but they are often inadequate; the American College of Cardiology no longer recommends that all patients try lifestyle modification alone before adding...
Med Lett Drugs Ther. 2025 Aug 4;67(1734):121-8   doi:10.58347/tml.2025.1734a |  Show IntroductionHide Introduction

Two New Drugs for Gonorrhea

   
The Medical Letter on Drugs and Therapeutics • Mar 16, 2026  (Issue 1750)
Two New Drugs for Gonorrhea ...
The FDA has approved two antibiotics, gepotidacin (Blujepa — GSK) and zoliflodacin (Nuzolvence — Entasis), for oral treatment of uncomplicated urogenital gonorrhea in patients ≥12 years old. Gepotidacin is approved for use in persons weighing ≥45 kg who have limited or no alternative treatment options; it was approved in 2025 for treatment of uncomplicated urinary tract infection in females. Zoliflodacin is approved for use in persons weighing ≥35 kg. Neither drug is indicated for treatment of rectal or pharyngeal gonorrhea.
Med Lett Drugs Ther. 2026 Mar 16;68(1750):41-3   doi:10.58347/tml.2026.1750a |  Show IntroductionHide Introduction

Topical Drugs For Vaginal Candidiasis

   
The Medical Letter on Drugs and Therapeutics • Aug 23, 1991  (Issue 851)
Topical Drugs For Vaginal Candidiasis ...
Many drugs, mostly imidazole derivatives, are marketed in the USA for topical treatment of vulvovaginal candidiasis, and a few are now available without a prescription.
Med Lett Drugs Ther. 1991 Aug 23;33(851):81 |  Show IntroductionHide Introduction

Safety of Smoking Cessation Drugs

   
The Medical Letter on Drugs and Therapeutics • Aug 24, 2009  (Issue 1319)
Safety of Smoking Cessation Drugs ...
The most effective drugs available for treatment of tobacco dependence are bupropion (Zyban, and others and varenicline (Chantix). The FDA recently ordered the manufacturers of both to add boxed warnings about the risk of psychiatric symptoms and suicide to their prescribing information (FDA Alert, 7/1/2009).
Med Lett Drugs Ther. 2009 Aug 24;51(1319):65 |  Show IntroductionHide Introduction

Grapefruit Juice Interactions With Drugs

   
The Medical Letter on Drugs and Therapeutics • Aug 18, 1995  (Issue 955)
Grapefruit Juice Interactions With Drugs ...
In a study of the interaction between alcohol and the calcium-channel blocker felodipine (Plendil), the grapefruit juice vehicle for the alcohol appeared to increase felodipine plasma concentrations. Subsequent studies have found that grapefruit juice increases plasma concentrations of several calcium-channel blockers and of some other drugs as well (DG Bailey et al, Clin Pharmacokinet, 26:91, 1994).
Med Lett Drugs Ther. 1995 Aug 18;37(955):73-4 |  Show IntroductionHide Introduction

Drugs of Choice for Cancer Chemotherapy

   
The Medical Letter on Drugs and Therapeutics • Mar 31, 1995  (Issue 945)
Drugs of Choice for Cancer Chemotherapy ...
Med Lett Drugs Ther. 1995 Mar 31;37(945):25-32 |  Show IntroductionHide Introduction

Two Drugs for Weight Loss

   
The Medical Letter on Drugs and Therapeutics • Sep 03, 2012  (Issue 1398)
Two Drugs for Weight Loss ...
In 2013 the FDA approved one new drug and a new combination of 2 old drugs as adjuncts to lifestyle changes for chronic weight management. Lorcaserin (lor-ca-SER-in; Belviq – Arena/Esai) is a selective serotonin 2C receptor agonist. Qsymia (Vivus) is a fixed-dose combination of the weight-loss drug phentermine and an extended-release (ER) formulation of topiramate. The new products are approved for use in obese patients (body mass index [BMI] of ≥30 kg/m2) and for patients who are overweight (BMI ≥27 kg/m2) and have one weight-related risk factor such as hypertension, dyslipidemia or...
Med Lett Drugs Ther. 2012 Sep 3;54(1398):69-71 |  Show IntroductionHide Introduction

New Drugs for Multiple Sclerosis

   
The Medical Letter on Drugs and Therapeutics • Nov 12, 2012  (Issue 1403)
New Drugs for Multiple Sclerosis ...
In recent years, several new drugs have been approved by the FDA for use in multiple sclerosis (MS), and many others are in the pipeline. Most recently, teriflunomide (Aubagio – Genzyme) became the second oral drug to be approved by the FDA for treatment of relapsing forms of MS.
Med Lett Drugs Ther. 2012 Nov 12;54(1403):89-91 |  Show IntroductionHide Introduction